PHT-427

Catalog No.S1556 Batch:S155601

Print

Technical Data

Formula

C20H31N3O2S2
Molecular Weight 409.61 CAS No. 1191951-57-1
Solubility (25°C)* In vitro DMSO 82 mg/mL (200.19 mM)
Ethanol 60 mg/mL (146.48 mM)
Water Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description PHT-427 (CS-0223) is a dual Akt and PDPK1 inhibitor (high affinity binding for the PH domains of Akt and PDPK1) with Ki of 2.7 μM and 5.2 μM, respectively.
Targets
Akt [1] PDPK1 [1]
2.7 μM(Ki) 5.2 μM(Ki)
In vitro PH-427 is a pleckstrin homology domain inhibitor to Akt/PDPK1. PH-427 significantly reduces phospho-Ser241-PDPK1 phospho-Thr308-Akt in PC-3 prostate cancer cells at 10 μM, which shows that PHT-427 could inhibit both Akt and PDPK1. PHT-427 also inhibits translocation of the Akt and PDPK1 PH domains in plasma membrane. [1] PHT-427 induces apoptosis and inhibits AKT phosphorylation with IC50 of 8.6 μM (in BxPC-3 cells), which mainly on its Ser473 residue and less strongly on Thr308 residue without affecting total Akt protein expression. PHT-427 also shows antiproliferation in Panc-1 cells with IC50 of 65 μM. [2]
In vivo PHT-427 shows great antitumor activity in BxPC-3 pancreatic, MCF-7 breast and A-549 NSCL cancer xenografts. PHT-427 gives up to an 80% inhibition of tumor growth in BxPC-3 at doses of 125 to 250 mg/kg. [1]

Protocol (from reference)

Kinase Assay:[1]
  • Surface plasmon resonance (SPR) spectroscopy binding assays

    All interaction analyses are performed with a Biacore 2000, Biacore 2000 Control Software v3.2, and BIAevaluation v4.1 analysis software. The PH domain GST-fusion proteins (Akt1, IRS1, and PDK1) are immobilized on a CM5 Sensorchip using Biacore's Amine Coupling Kit to a level of 10,000 Response units (RUs). Small molecule analytes at concentrations ranging from 0.1 to 10 × the predicted KD are injected at a high flow rate (30μL/min). DMSO concentrations in all samples and running buffer are 1% (v/v) or less.
Animal Study:[1]
  • Animal Models

    BxPC-3, Panc-1, MiaPaCa-2, PC-3, SKOV-3, A-549 or MCF-7 cells are injected subcutaneously into the flanks of female scid mice.

  • Dosages

    125-250 mg/kg

  • Administration

    Oral administration

Customer Product Validation

Data from [Data independently produced by Eur J Pharmacol, 2014, 747C, 71-87]

Data from [Blood, 2011, 118, 2840-2848]

Data from [Data independently produced by , , Research Letter, 2018, doi:org/10.1002/1873-3468.13305]

Selleck's PHT-427 has been cited by 20 publications

Functional restoration of lysosomes and mitochondria through modulation of AKT activity ameliorates senescence [ Exp Gerontol, 2023, 173:112091] PubMed: 36657533
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia [ Cancer Cell, 2022, S1535-6108(22)00312-9] PubMed: 35868306
Telomerase RNA TERC and the PI3K-AKT pathway form a positive feedback loop to regulate cell proliferation independent of telomerase activity [ Nucleic Acids Res, 2022, gkac179] PubMed: 35323972
Identification of a New Antimicrobial Agent against Bovine Mastitis-Causing Staphylococcus aureus [ J Agric Food Chem, 2021, 10.1021/acs.jafc.1c02738] PubMed: 34406764
Patient-specific logic models of signaling pathways from screenings on cancer biopsies to prioritize personalized combination therapies. [ Mol Syst Biol, 2020, 16(2):e8664] PubMed: 32073727
Genipin, a natural AKT inhibitor, targets the PH domain to affect downstream signaling and alleviates inflammation [ Biochem Pharmacol, 2019, 170:113660] PubMed: 31605673
A natural AKT inhibitor swertiamarin targets AKT-PH domain, inhibits downstream signaling, and alleviates inflammation. [ FEBS J, 2019, 10.1111/febs.15112] PubMed: 31665825
The flavonoid baicalin improves glucose metabolism by targeting the PH domain of AKT and activating AKT/GSK3β phosphorylation. [ FEBS Lett, 2019, 593(2):175-186] PubMed: 30489635
A microfluidics platform for combinatorial drug screening on cancer biopsies. [ Nat Commun, 2018, 9(1):2434] PubMed: 29934552
Chlorogenic Acid Targeting of the AKT PH Domain Activates AKT/GSK3β/FOXO1 Signaling and Improves Glucose Metabolism. [ Nutrients, 2018, 10(10)] PubMed: 30249058

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.